Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced the launch of All Eyes on DME, a campaign ...

Roche’s Genentech unit is launching a new multimedia campaign aimed at sharing the stories of people living with diabetes and ...

These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...

Comedy icon Damon Wayans was diagnosed with Type 2 diabetes in 2008. Now, he is teaming up with Genentech and diaTribe as he ...

Pancreatic cancer kills roughly nine out of every ten people diagnosed with it, most within five years. So when researchers ...

Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon as Monday.

Genentech recently announced a series of marketing leadership hires to start off the new year. The biotech company hired Erica Taylor, PhD, as the company’s first chief marketing officer and tabbed ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...

Biotechnology company Genentech is expanding its local manufacturing capabilities with a $450 million investment in its Oceanside campus. Genentech was founded in 1976 and has been considered a ...